1-5 of 5
Shariful Islam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multi-Modal Analysis of Acquired Resistance to Acalabrutinib and Pirtobrutinib Provides Potential Strategies to Augment Treatment Outcome with BTKi Drugs

Xiaoyun Wu, Shariful Islam, Derek B Oien, Collin Tokheim, Alex Beacom, Neeraj Aryal, Michelle Hsueh, Muskan Floren, Douglas Ross-Thriepland, Daniel Barrell, Ultan McDermott, Veerendra Munugalavadla, Daniel Auclair, Simon Rule, Arthur Shaffer, Jude Fitzgibbon, Lisa Drew
Journal: Blood
Blood (2023) 142 (Supplement 1): 1452.
https://doi.org/10.1182/blood-2023-189924
Published: 2023
Journal Articles

Multi-Omics of Aurora Inhibition Induced Polyploidy Reveals Mechanisms of Disease Relapse in MYC/BCL2-Addicted High Grade B-Cell Lymphoma

Shariful Islam, Andrew Paek, PhD, Michael Hammer, PhD, Savithri Rangarajan, PhD, Robert Ruijtenbeek, PhD, Laurence Cooke, MS, Eric Weterings, PhD, Daruka Mahadevan, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1572.
https://doi.org/10.1182/blood-2018-99-109975
Published: 2018
Journal Articles

Oncolytic Reovirus Is an Effective Treatment for Histone Deacetylase Inhibitor Resistant T-Cell Lymphoma

Shariful Islam, Claudia M Espitia, Ning Qu, MD PhD, Daniel Persky, MD, Jennifer S. Carew, PhD, Steffan T. Nawrocki, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2941.
https://doi.org/10.1182/blood-2018-99-119152
Published: 2018
Journal Articles

RX-3117, a Novel Nucleoside Analog Targeting UCK2 Is Active Alone and Synergistic with Ibrutinib and Bendamustine in ABC and DH/DP- Diffuse Large B-Cell Lymphoma

Shariful Islam, Umar Zahid, MD, Laurence Cooke, MS, Young Bok Lee, Deog Joong Kim, Ely Benaim, MD, Daruka Mahadevan, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5196.
https://doi.org/10.1182/blood.V130.Suppl_1.5196.5196
Published: 2017
Journal Articles

Alisertib-Induced Polyploidy and Senescence in DH/DP-DLBCL Is Abrogated By Synthetic Lethal Interactions with Ibrutinib and Rituximab

Shariful Islam, MS, Wenqing Qi, PhD, Carla Morales, B.S., Laurence Cooke, M.S., Manjari Pandey, MD, Catherine M. Spier, MD, Daruka Mahadevan, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5397.
https://doi.org/10.1182/blood.V128.22.5397.5397
Published: 2016